Sanofi seeks use of type 1 diabetes drug in younger kids
Sanofi could be months away from wider US approval for Tzield, its first-in-class drug for delaying the progression of type 1 diabetes (T1D), in children as young as one. The…
Sanofi could be months away from wider US approval for Tzield, its first-in-class drug for delaying the progression of type 1 diabetes (T1D), in children as young as one. The…
Share on PinterestA few simple habits may help keep the brain younger, even in people living with chronic pain. Image credit: Thomas Barwick/Getty Images A new study from researchers at…
CureusEarly-Onset Type 2 Diabetes: A Comprehensive Review From Adolescence to AdulthoodType 2 diabetes mellitus, traditionally considered a disease of adults, is increasingly being diagnosed in younger individuals,….11 hours ago